Scientists at the University of Oxford, led by Professor Ahmed Ahmed, are designing OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.
In this study, the CRUK-funded researchers will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognised by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.
If this research is successful, work will then begin on clinical trials of the vaccine. The hope is that in the future, women could be offered this vaccine to prevent ovarian cancer in the first place.
Read the full story on the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) website.
more recommended stories
Can Ketogenic Diets Help PCOS? Meta-Analysis InsightsKey Takeaways (Quick Summary) A Clinical.
Silica Nanomatrix Boosts Dendritic Cell Cancer TherapyKey Points Summary Researchers developed a.
Vagus Nerve and Cardiac Aging: New Heart StudyKey Takeaways for Healthcare Professionals Preserving.
Cognitive Distraction From Conversation While DrivingKey Takeaways (Quick Summary) Talking, not.
Fat-Regulating Enzyme Offers New Target for ObesityKey Highlights (Quick Summary) Researchers identified.
Spatial Computing Explains How Brain Organizes CognitionKey Takeaways (Quick Summary) MIT researchers.
Gestational Diabetes Risk Identified by Blood MetabolitesKey Takeaways (Quick Summary for Clinicians).
Phage Therapy Study Reveals RNA-Based Infection ControlKey Takeaways (Quick Summary) Researchers uncovered.
Pelvic Floor Disorders: Treatable Yet Often IgnoredKey Takeaways (Quick Summary) Pelvic floor.
Urine-Based microRNA Aging Clock Predicts Biological AgeKey Takeaways (Quick Summary) Researchers developed.
Leave a Comment